Login to Your Account

Voluntary reporting to help shape FDA’s quality metrics program

By Mari Serebrov
Regulatory Editor

Wednesday, November 23, 2016

Calling all drug companies – the FDA wants your quality manufacturing data. The agency is launching a voluntary phase of its quality metrics reporting program in hopes of learning more about certain quality metrics and associated analytics.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription